Skip to main content
Clinical Trials/JPRN-UMIN000036457
JPRN-UMIN000036457
Completed
未知

Exploratory study of blood biomarkers to predict the therapeutic effect of nintedanib in idiopathic pulmonary fibrosis (IPF) - OFBIO study

Chiba University Hospital, Respiratory medicine0 sites100 target enrollmentMay 1, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
idiopathic pulmonary fibrosis (IPF)
Sponsor
Chiba University Hospital, Respiratory medicine
Enrollment
100
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 1, 2019
End Date
March 31, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Chiba University Hospital, Respiratory medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1 Patients who can not get consent 2 patients whom the doctor in charge deems inappropriate 3 Patients with acute exacerbation at time 4 Patients with malignancy 5 Patients scheduled for surgery within 6 months 6 Patients with severe liver disorder (Child\-Pugh B or more) 7 Patients whose prognosis is predicted to be less than 6 months

Outcomes

Primary Outcomes

Not specified

Similar Trials